Truepoint Inc’s MetLife MET Stock Holding History

Truepoint Inc’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,371	Closed	-$355K	–	196
2023 Q4	$355K	Buy	5,371 +2,063	+62%	+$129K	0.01%	154
2023 Q3	$208K	Buy	+3,308	New	+$206K	0.01%	188

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Truepoint Inc's MET Position: Q1 2024 in Review

Truepoint Inc sold out of MetLife (MET) in Q1 2024, closing a stake of 5,371 shares — an estimated $355K sold.

Truepoint Inc first reported a position in MET in Q3 2023 and held it in 2 quarters. The position peaked at $355K in Q4 2023. 1,281 funds tracked by Wall St. Rank hold MET as of Q1 2024.

Truepoint Inc reported no remaining MetLife position as of Q1 2024 after selling out during the quarter.
Truepoint Inc sold 5,371 MetLife shares in Q1 2024, an estimated $355K.
Truepoint Inc first reported a position in MetLife in Q3 2023 and held it in 2 quarters.
Truepoint Inc's MetLife position peaked at $355K in Q4 2023.
1,281 funds tracked by Wall St. Rank held MetLife as of Q1 2024.

Based on Truepoint Inc's 13F filing for Q1 2024, filed 9 May 2024.